netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

 

NHS Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation B04/P/a

Contacting Milton Keynes Hospital

      
For Haematology and Oncology:

  • During hours: Macmillan Unit on 01908 243671; Internal Ext 5111 or 5112
  • Out of hours: Advanced Nurse Practitioner on bleep 1090    

Paediatric patients:

  • During hours: Paediatric Day Community Unit on 01908 242703; Internal Ext 2703      

Pharmacy:

  • Cancer and Aseptic Services Manager on bleep 1721
  • Aseptic Unit 01908 243952
  • On-call pharmacist via switchboard 01908 660033
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (3,2)
Side-effects of cytotoxic drugs (0,1)
Drugs for cytotoxic-induced side-effects (2,6)
08.01.01 Alkylating drugs (10,4)
08.01.02 Anthracyclines and other cytotoxic antibiotics (11,0)
08.01.03 Antimetabolites (14,4)
08.01.04 Vinca alkaloids and etoposide (6,0)
08.01.05 Other antineoplastic drugs (28,11)
Amsacrine (1,0)
Arsenic trioxide (1,0)
Bevacizumab (1,0)
Bexarotene (0,1)
Bortezomib (1,0)
Brentuximab vedotin (1,0)
Cetuximab (1,0)
Crisantaspase (1,0)
Dacarbazine and Temozolomide (2,0)
Erlotinib (1,0)
Hydroxycarbamide (1,0)
Imatinab (0,0)
Ipilimumab (1,0)
Mitotane (0,1)
Panitumumab (0,0)
Pentostatin (1,0)
Platinum compounds (3,0)
Porfimer sodium and temoporfin (0,2)
Procarbazine (1,0)
Protein kinase inhibitors (18,1)
Taxanes (3,1)
Topoisomerase I inhibitors (1,1)
Trabectedin (1,0)
Trastuzumab (3,2)
Tretinoin (1,0)
Vismodegib (1,0)
08.02 Drugs affecting the immune response (1,0)
Immunosuppressant therapy (0,0)
08.02.01 Antiproliferative immunosuppressants (2,2)
08.02.02 Corticosteroids and other immunosuppressants (4,12)
08.02.03 Anti-lymphocyte monoclonal antibodies (9,1)
08.02.04 Other immunomodulating drugs (16,6)
Interferon Alfa (2,4)
Interferon beta (5,1)
Interferon gamma (0,0)
Aldesleukin (1,2)
BCG bladder instillation (0,0)
Canakinumab (0,0)
Dimethyl fumarate (0,0)
Fingolimod (0,0)
Glatiramer acetate (1,0)
Histamine (0,0)
Lenalidomide, pomalidomide, and thalidomide (0,0)
Mifamurtide (1,0)
Natalizumab (1,0)
Teriflunomide (0,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (2,0)
08.03.02 Progestogens (3,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (7,3)
08.03.04.02 Prostate cancer and gonadorelin analogues (0,2)
Gonadorelin analogues (1,1)
Anti-androgens (5,7)
08.03.04.03 Somatostatin analogues (3,2)
netFormulary